Align Technology Inc. (ALGN)

388.96
NASDAQ : Health Technology
Prev Close 388.96
Day Low/High 0.00 / 0.00
52 Wk Low/High 180.31 / 393.98
Avg Volume 722.20K
Exchange NASDAQ
Shares Outstanding 80.32M
Market Cap 30.59B
EPS 2.90
P/E Ratio 105.50
Div & Yield N.A. (N.A)

Latest News

Invisalign® Clear Aligners Voted #1 Most Popular Wedding Beauty Treatment For Brides

Invisalign® Clear Aligners Voted #1 Most Popular Wedding Beauty Treatment For Brides

According to a New Study by RealSelf, Invisalign Product Reviews Contained the Largest Percentage of Wedding Preparation Mentions

9 Stocks Goldman Sachs Thinks Will Blow Wall Street's Performance Away in 2019

9 Stocks Goldman Sachs Thinks Will Blow Wall Street's Performance Away in 2019

Investors will soon turn their attention to Corporate America's outlook for 2019. Here are several stocks that are worth a look.

Jim Cramer: Beauty Is In the Eye of the Investor

Jim Cramer: Beauty Is In the Eye of the Investor

Investors love the fintech space, the growth entertainment sector, the cloud and the med tech.

Jim Cramer: This Rally Is All About China Blinking

Jim Cramer: This Rally Is All About China Blinking

When you get no instant retaliation from China and instead get the companies trying to crack into China see their stocks rallying, it emboldens you to think, wow, I don't want to be cross-wise with this one.

Get Used to Uncertainty: Cramer's 'Mad Money' Recap (Tuesday 5/29/18)

Get Used to Uncertainty: Cramer's 'Mad Money' Recap (Tuesday 5/29/18)

Global uncertainty, interest rates, and profit-taking are weighing on the markets. But Jim Cramer argues these events are good for the U.S.

Berkshire Hathaway, Align Technology, Seaspan: 'Mad Money' Lightning Round

Berkshire Hathaway, Align Technology, Seaspan: 'Mad Money' Lightning Round

Jim Cramer focuses on Berkshire Hathaway, Align Technology, Seaspan, Criticare Systems, CoreSite Realty, Hi-Crush Partners and more.

Is This Rally for Real?: Cramer's 'Mad Money' Recap (Monday 5/14/18)

Is This Rally for Real?: Cramer's 'Mad Money' Recap (Monday 5/14/18)

Jim Cramer asks, why is there such a double-standard? Why do selloffs have instant credibility and advances are to be doubted?

Regions Financial, Edwards Lifesciences: 'Mad Money' Lightning Round

Regions Financial, Edwards Lifesciences: 'Mad Money' Lightning Round

Jim Cramer focuses on Regions Financial, Edwards Lifesciences, Align Technology, Applied Materials, Qualys, HEICO and more.

Not Thankful for Fridays: Cramer's 'Mad Money' Recap (Friday 4/20/18)

Not Thankful for Fridays: Cramer's 'Mad Money' Recap (Friday 4/20/18)

Jim Cramer says analysts and trade woes put a damper on buying ahead of the weekend. So let's get the game plan for next week.

American Airlines, ABB Ltd., Salesforce.com: 'Mad Money' Lightning Round

American Airlines, ABB Ltd., Salesforce.com: 'Mad Money' Lightning Round

Jim Cramer focuses on American Airlines, Salesforce.com, Realty Income, Proctor & Gamble, United Bankshares, iRobot, Dominion Energy.

Rally Climbs on Earnings: Cramer's 'Mad Money' Recap (Thursday 4/12/18)

Rally Climbs on Earnings: Cramer's 'Mad Money' Recap (Thursday 4/12/18)

Good earnings reports, cooling oil, and tech leadership all contributed to Thursday's gains, says Jim Cramer. Along with no explosive presidential tweets.

Align Technology Introduces Invisalign Clear Aligners For Phase 1 Treatment Of Younger Patients With Early Mixed Dentition

Align Technology Introduces Invisalign Clear Aligners For Phase 1 Treatment Of Younger Patients With Early Mixed Dentition

Invisalign® First Increases Invisalign Applicability to 70 Percent of Annual Orthodontic Case Starts Worldwide

Deere and Co., Henry Schein, Fitbit: 'Mad Money' Lightning Round

Deere and Co., Henry Schein, Fitbit: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Henry Schein, Deere and Co., Fitbit, Smart Global Holdings, Applied Materials and Splunk.

Amazon Gets Slammed: Cramer's 'Mad Money' Recap (Wednesday 3/28/18)

Amazon Gets Slammed: Cramer's 'Mad Money' Recap (Wednesday 3/28/18)

In this fickle and volatile market, Jim Cramer muses about how powerhouse Amazon gets hit hard, while his favorite old classic, Clorox, cleans up.

Cramer: Hunting for Bargains

Cramer: Hunting for Bargains

How do we examine what might be attractive when the selling madness really abates?

Emerson Electric, S&P Global, Ball Corp.: 'Mad Money' Lightning Round

Emerson Electric, S&P Global, Ball Corp.: 'Mad Money' Lightning Round

Jim Cramer focuses on S&P Global, Myriad Genetics, ProLogis, Emerson Electric, Ball Corp. and more.

Don't Fall for the Downward Bias: Cramer's 'Mad Money' Recap (Thursday, 2/1/18)

Don't Fall for the Downward Bias: Cramer's 'Mad Money' Recap (Thursday, 2/1/18)

Jim Cramer says being a realistic investor doesn't mean being negative, especially when solid reality supports optimism.

Align Technology Takes Over #255 Spot From Welltower

Align Technology Takes Over #255 Spot From Welltower

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Align Technology Inc has taken over the #255 spot from Welltower Inc , according to The Online Investor. Market capitalization is an important data point for investors to keep an eye on, for various reasons.

7 Investment Themes You Can't Afford to Miss for 2018

7 Investment Themes You Can't Afford to Miss for 2018

The 'winning formula' for this year focuses on growth, size and foreign stocks, Jefferies says.

Feed the Beast: Cramer's 'Mad Money' Recap (Thursday 1/4/18)

Feed the Beast: Cramer's 'Mad Money' Recap (Thursday 1/4/18)

Jim Cramer says this beast of a bull market is getting a steady diet of healthful sector opportunities.

Cramer: 2017 Was a Year of Resurrection and Revival

Cramer: 2017 Was a Year of Resurrection and Revival

Look no further than the top 10 winners in the S&P 500 and you will see just what I mean.

Align Technology's Big Rally Is Starting to Slow

Align Technology's Big Rally Is Starting to Slow

The charts are not showing sell signals, but consider raising sell-stop protection to a close below $220.

TheStreet Quant Rating: B (Buy)